Continuing Medical Education For HCPs
Staying updated with the latest advancements in cancer health is essential for healthcare professionals. Our Continuing Medical Education (CME) resources offer in-depth insights into the evolving landscape of oncology. Explore a range of educational materials designed to empower medical professionals with the knowledge needed to offer the best possible care to patients dealing with cancer. Stay informed about the latest treatment approaches, research findings, and innovative therapies.
Sponsored By
Evaluation and Treatment of Patients With Dermatologic Diseases
This is a training, natural history of disease, and screening protocol for the evaluation, treatment and follow-up of patients with dermatologic diseases and systemic diseases with cutaneous manifesta ...
Condition: Dermatologic Diseases
Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer
RATIONALE: Vaccines may help the body build an effective immune response to kill tumor cells.
Colony-stimulating factors, such as GM-CSF, may increase the number of immune cells found in bone mar ...
Condition: HER2-positive Breast Cancer
Breast MRI as a Preoperative Tool for DCIS
Breast MRI is a fairly new technology, but it has been well studied.
It is now used routinely in many patients with breast cancer.
It has been shown to be useful in detecting areas of can ...
Condition: Breast Cancer
Efficacy and safety of blinatumomab in Chinese patients with relapsed/refractory B-cell acute lymphoblastic leukemia: a single-center retrospective study
Background: Blinatumomab is a bispecific T-cell engager approved for the treatment of relapse/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL). Most studies evaluating blinatumomab were cond
Severe outcomes and risk factors of non-neutropenic fever episodes in hospitalized children with cancer in Kenya
Introduction: Compared to febrile neutropenia (FN), non-neutropenic fever (NNF) episodes in children with cancer have not been associated with severe outcomes. Risk factors for severe outcomes in FN a
Mesenchymal stromal cells for steroid-refractory biopsy-proven grade III-IV acute Graft-versus-Host Disease with predominant gastrointestinal involvement
Introduction: Steroid-refractory acute Graft-versus-Host Disease (SR-aGVHD) is a potentially fatal complication occurring in approximately 60-70% of severe grade III-IV GVHD cases, with a higher incid
What is a Renal Mass? - Urology Care Foundation
In this updated Urology Care Foundation patient education video, we answer the question, "What is a renal mass?" For more ...
5 Urological emergencies everybody should know | UroChannel
Many people are not aware of urological emergencies that can affect everybody. Some of them are very common, some are not.
Get the Facts about Hematuria - Urology Care Foundation
In this Urology Care Foundation patient education video, get facts about Hematuria (or blood in the urine). What are the symptoms ...